Multimodality approaches for pancreatic cancer

Gary Y. Yang, Timothy D. Wagner, Martin Fuss, Charles R. Thomas

Research output: Contribution to journalReview article

26 Scopus citations

Abstract

The role of combined-modality therapy for pancreatic cancer is evolving with the recent development and completion of major, multi-institutional clinical trials. One of the challenges for the busy clinician is to appreciate the variation in staging, surgical expertise, and application of either definitive chemoradiotherapy or adjuvant chemoradiotherapy for local and/or regionally advanced disease. Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)352-367
Number of pages16
JournalCa-A Cancer Journal for Clinicians
Volume55
Issue number6
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Multimodality approaches for pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this